Health Technology Assessment: New Opportunity to Apply for Joint Scientific Consultations
Abstract
The Commission has opened the first submission period for joint scientific consultations (JSCs) for 2026. JSCs enable health technology developers (pharma and medtech companies) to consult with the Health Technology Assessment agencies in the Member States on how their clinical studies should be conducted to best prepare for a potential Joint Clinical Assessment. Read the e-News published by DG Health and Food Safety on 7 January 2026.
Fields of Study & Subjects
Health Systems
Economic Evaluations
Quality of Life
Healthcare Regulation
Pharmaceutical Economics and Policy
Publication details
- Journal / source
- Hypotheses (OpenEdition)
- Publication date
- 16 February 2026
- Language
- EN